Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

1.1K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.1K
Types of Hormones02:13

Types of Hormones

83.8K
Hormones can be classified into three main types based on their chemical structures: steroids, peptides, and amines. Their actions are mediated by the specific receptors they bind to on target cells.
83.8K
Types of Hormones01:21

Types of Hormones

7.2K
Hormones are classified into four main groups: steroids, eicosanoids, amino acid-based derivatives, and peptide hormones.
Steroids and eicosanoids fall under the category of lipid-soluble hormones. Steroids are derived from cholesterol and feature four interconnected carbon rings with variable side chains. Notable examples include estradiol from ovaries and testosterone from testes, exemplifying the critical roles of these lipid-soluble hormones in reproductive physiology. Eicosanoids, derived...
7.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

229
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
229
Hormonal Regulation01:33

Hormonal Regulation

36.1K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.1K
Hormonal Regulation01:40

Hormonal Regulation

48.3K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
48.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vitro Percutaneous Absorption of Permeation-Enhancing Estrogen Formulations.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Testosterone Therapy for Late-Onset Hypogonadism: A Clinical, Biological, and Analytical Approach Using Compounded Testosterone 0.5-20% Topical Gels.

Pharmaceutics·2024
Same author

Establishing a Rationale for Compounding Hormone Replacement Therapy.

International journal of pharmaceutical compounding·2024
Same author

Treatment Options for Male Hypogonadism.

International journal of pharmaceutical compounding·2024
Same author

Hormone Treatment Options for Males: What to do for Men with Low Testosterone.

International journal of pharmaceutical compounding·2024
Same author

Major Study Affirming the Relative Safety of Testosterone-replacement Therapy.

International journal of pharmaceutical compounding·2023
Same journal

Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions.

International journal of pharmaceutical compounding·2026
Same journal

Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.

International journal of pharmaceutical compounding·2026
Same journal

Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.

International journal of pharmaceutical compounding·2026
Same journal

Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base.

International journal of pharmaceutical compounding·2026
Same journal

Formulation and In-Vitro Characterization of Gastroretentive Effervescent Floating Tablets of Meloxicam.

International journal of pharmaceutical compounding·2026
Same journal

Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.

International journal of pharmaceutical compounding·2026
See all related articles

Related Experiment Video

Updated: Feb 9, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.5K

Establishing a Rationale for Compounding Hormone Replacement Therapy.

Bruce Biundo1

  • 1Professional Compounding Centers of America (PCCA), Houston, Texas. bbiundo@pccarx.com.

International Journal of Pharmaceutical Compounding
|June 8, 2018
PubMed
Summary
This summary is machine-generated.

Compounded bioidentical hormones offer unique, patient-specific options beyond commercial products. Pharmacists leverage growing knowledge of estrogen receptors alpha and beta for tailored hormone therapy.

More Related Videos

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.3K
Monitoring Plant Hormones During Stress Responses
11:01

Monitoring Plant Hormones During Stress Responses

Published on: June 15, 2009

17.0K

Related Experiment Videos

Last Updated: Feb 9, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

1.5K
Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay
07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

9.3K
Monitoring Plant Hormones During Stress Responses
11:01

Monitoring Plant Hormones During Stress Responses

Published on: June 15, 2009

17.0K

Area of Science:

  • Endocrinology and Pharmaceutical Sciences
  • Focus on hormone receptor interactions and therapeutic applications.

Background:

  • Physicians and practitioners inquire about the necessity and uniqueness of compounded bioidentical hormones.
  • The market landscape for hormone replacement therapy has evolved, with commercial bioidentical estradiol and progesterone products now available.
  • Traditional market leaders like Premarin are no longer dominant.

Purpose of the Study:

  • To address the evolving questions surrounding compounded bioidentical hormone therapies.
  • To articulate the distinct advantages offered by compounding pharmacists.
  • To highlight the significance of advancing knowledge in hormone receptor science.

Main Methods:

  • Comparative analysis of compounded therapies versus available commercial hormone products.
  • Review of current understanding of estrogen receptor subtypes (alpha and beta).
  • Discussion of the evolving challenges in marketing compounded hormone therapies.

Main Results:

  • Compounding pharmacists provide unique, patient-specific hormone preparations.
  • Commercial options for bioidentical estradiol (topical) and progesterone (capsules) now exist.
  • Understanding of estrogen receptor beta is a significant factor in current therapeutic strategies.

Conclusions:

  • The primary advantage of compounded bioidentical hormones lies in customization for individual patient needs.
  • Advances in understanding estrogen receptor biology, particularly estrogen receptor beta, enhance the precision of hormone therapy.
  • Compounded therapies remain a vital option, adapting to market changes and scientific discoveries.